Jan Buter
- Oncology top 2%
- Pulmonary and Respiratory Medicine top 2%
- Otorhinolaryngology top 0.5%
- Surgery top 5%
- Molecular Biology
- Co-authors
- C. René LeemansJohannes A. LangendijkI. van der WaalBen J. SlotmanR.I.F. van der WaalRemco de BreeJohannes BerkhofGiuseppe Giaccone
- Topics
- Head and Neck Cancer Studies (28 papers)Glioma Diagnosis and Treatment (16 papers)Lung Cancer Treatments and Mutations (12 papers)
- Partner nations
- NetherlandsUnited StatesGermany
In The Last Decade
Jan Buter
89 papers receiving 3.1k citations
Peers
Comparison fields: 5 of 119
- Oncology 1.5k
- Pulmonary and Respiratory Medicine 924
- Otorhinolaryngology 867
- Surgery 824
- Molecular Biology 450
Countries citing papers authored by Jan Buter
This map shows the geographic impact of Jan Buter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Buter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Buter more than expected).
Fields of papers citing papers by Jan Buter
This network shows the impact of papers produced by Jan Buter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Buter. The network helps show where Jan Buter may publish in the future.
Co-authorship network of co-authors of Jan Buter
This figure shows the co-authorship network connecting the top 25 collaborators of Jan Buter. A scholar is included among the top collaborators of Jan Buter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Buter. Jan Buter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 15 | |
| 3 | 18 | |
| 4 | 13 | |
| 5 | 76 | |
| 6 | 12 | |
| 7 | 38 | |
| 8 | 19 | |
| 9 | 78 | |
| 10 | 29 | |
| 11 | Serum S-100B Protein Is A Predictor of Survival in Recurrent Glioma | 1 |
| 12 | 86 | |
| 13 | 61 | |
| 14 | 56 | |
| 15 | 99 | |
| 16 | 8 | |
| 17 | 52 | |
| 18 | The hidden treasures of the primary tumor: Extended neoadjuvant chemotherapy plus GM-CSF in locally advanced cancer | 2 |
| 19 | 9 | |
| 20 | 10 |
About Jan Buter
Jan Buter is a scholar working on Otorhinolaryngology, Oncology and Genetics, having authored 89 papers that have together received 3.3k indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (28 papers), Glioma Diagnosis and Treatment (16 papers) and Lung Cancer Treatments and Mutations (12 papers). The work is most often cited by research in Otorhinolaryngology (867 citations), Oncology (1.5k citations) and Oral Surgery (254 citations). Jan Buter has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include C. René Leemans, Johannes A. Langendijk, I. van der Waal, Ben J. Slotman, R.I.F. van der Waal, Remco de Bree, Johannes Berkhof, Giuseppe Giaccone, Patricia Doornaert and Richard M. Kellogg. Their work appears in journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.